Europe PMC
open access
Early Cenobamate as a Third-Line Option in Drug-Resistant Focal Epilepsy: A Paradigm Shift?
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy#991835
- Study of Cannabidiol for Drug-Resistant Epilepsies#915304
- The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy#802846
- University of Alabama at Birmingham (UAB) Adult CBD Program#828277
- Drug-drug Interactions Between AZD4205 and Itraconazole/Carbamazepine#854075
Record · ID 253601
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive